Magnus Carlsen slams table after shock loss to Gukesh Dommaraju in Norway
World champion Gukesh Dommaraju earned his first classical victory over Magnus Carlsen on Sunday at the Norway Chess tournament in Stavanger, toppling the longtime world No 1 in dramatic fashion and prompting the Norwegian to punch the table in frustration before storming out of the venue.
The win in round six of the double round-robin event marked a milestone moment in Gukesh's young career, not for its stakes but for who it came against. Under pressure for much of the contest, the 19-year-old Indian grandmaster turned the tables in the final phase, capitalizing on a rare Carlsen blunder in time trouble to steal the point and shake up the standings in Stavanger.
Advertisement
'Right now, what means the most to me is that I didn't lose the game,' Gukesh said after the game. 'But yes, beating Magnus in any form is special.'
Carlsen had outplayed Gukesh with ease in their first-round meeting and looked poised to do so again, pressing from a superior position through the middlegame. But with both players operating on a 10-second increment, Carlsen faltered (52...Ne2+??). Gukesh defended doggedly and pounced when the Norwegian miscalculated, flipping the position with a precise counterattack.
The 34-year-old resigned shortly after then slammed his fist on the table, sending pieces rattling. It was an uncharacteristic display from the typically composed five-time world champion, who then left the hall immediately and skipped all media duties.
Advertisement
'Well, we could say it was lucky,' said Gukesh's coach Grzegorz Gajewski. 'But we have to give a lot of credit to Guki for his stubbornness and for his resourcefulness.'
The result not only evened their head-to-head in this tournament but delivered a quiet rebuke to Carlsen's recent criticism of Gukesh's classical performances. After winning their earlier encounter, Carlsen had posted 'You come at the king, you best not miss' on social media, an old Baltimore proverb that seemed to reinforce his aura as the game's enduring alpha.
On Sunday, it was the teenager whose aim was true. Gukesh, who became the youngest ever undisputed world champion in December and celebrated his 19th birthday last Thursday, has struggled for consistency since claiming the crown. He came into Sunday's round six with just one win in the tournament. The comeback against Carlsen could prove a needed confidence jolt heading into the closing rounds.
Carlsen, who's held the top slot in Fide's world rankings for nearly 15 straight years, strengthened his claim as the greatest player of any era in 2021, when he crushed Ian Nepomniachtchi in Dubai in his fourth defense of the world championship. But he decided against defending it for a fifth time in 2023, citing a lack of motivation.
The win lifts Gukesh to 8½ points, one behind Carlsen and the American Fabiano Caruana, with four rounds still to play. It also continues a trend of Indian breakthroughs in Stavanger: last year, R Praggnanandhaa became the first Indian to beat Carlsen in classical play at this event. Now Gukesh has followed and arguably gone one better.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Freestyle Chess' Grand Slam Tour Will Make its U.S. Debut at Wynn Las Vegas
LAS VEGAS--(BUSINESS WIRE)--Freestyle Chess, the innovative chess league co-founded by Magnus Carlsen and Jan Henric Buettner that prioritizes creativity over memorization, will bring their Grand Slam Tour to the United States for the first time this July. The event, hosted at Wynn Las Vegas, will kick off with 'Chesstival' on July 13, featuring current and former NBA players in a knockout-style chess tournament. Thanks to a partnership with $50,000 in total prize money will be donated to the charity of the winners' choice. The Grand Slam Tournament will follow from July 16 through July 20. 'Wynn Las Vegas offers an unparalleled stage to introduce Freestyle's high-energy, immersive format to the U.S. – not just as a game of strategy, but as a world-class spectator experience,' said Jan Henric Buettner, CEO and co-founder of Freestyle Chess. For the first time, chess fans can experience Freestyle Chess live, as the 2025 Grand Slam Tournament opens ticket sales to the public. Hosted in Wynn's 50,000-square-foot Lafite Ballroom, the event will bring the tour's dynamic energy to life with immersive production, live commentary, and storytelling. Fans can choose from three ticket tiers: general admission, VIP, and private booths with player meet-and-greets – designed to offer a world-class experience. Tickets start at $90 and are available for purchase here. 'I really believe Chesstival is one of the biggest paradigm shifts, along with Freestyle Chess, that the chess world has ever seen, and I think they're going to help grow the game,' said former NBA MVP and investor in Freestyle Chess, Derrick Rose. The event follows Freestyle Chess raising $20 million in funding from venture capital firms such as Left Lane Capital, as well as athletes like Derrick Rose to support the expansion of its operations and global footprint. The league features top-ranked players such as five-time World Chess Champion Magnus Carlsen, reigning World Chess Champion Gukesh Dommaraju, and former World Rapid Champion Hikaru Nakamura. Each Grand Slam Tournament event offers $750,000 in prize money, setting a new benchmark for chess as a global sport. The championship at the end of the tour will crown the first Freestyle Chess Champion, marking a historic milestone in the evolution of the game. Following the rules of Chess960 (Fischer Random), which randomizes starting positions, Freestyle Chess emphasizes creativity and strategy, leveling the playing field for even the world's best players. For more information, please visit the Freestyle Chess website here. About Freestyle Chess Freestyle Chess was founded in 2024 by Magnus Carlsen and Jan Henric Buettner, to revolutionize the game of chess. Capitalizing on the boom of interest in the sport, Freestyle Chess incorporates a unique style of gameplay featuring Fischer Random and follows the players' heart rates throughout the matches. Working to democratize the sport, matches are available for free online, and players participate in press conferences and post-match interviews, keeping the company's events exciting for all audiences. This year, Freestyle Chess kicked off its Grand Slam tournaments in Germany, France with upcoming stops in the United States and South Africa.


Medscape
5 hours ago
- Medscape
Does Initial Progression of SSc-ILD Mean More Is to Come?
Interstitial lung disease (ILD) progression in patients with systemic sclerosis–associated ILD (SSc-ILD) did not predict subsequent progression at the next annual follow-up, with only 20% showing further progression. However, initial ILD progression was associated with an increased risk for mortality. METHODOLOGY: Researchers conducted a multicenter observational study to evaluate whether an observed progression of ILD in patients with SSc-ILD leads to a risk for subsequent progression. They included 231 patients with SSc-ILD in the main cohort (mean age, 48 years; 76% women; mean disease duration, 10.4 years) from Oslo, Norway, and Zurich, Switzerland, enrolled between January 2001 and December 2019. Pulmonary function tests measuring forced vital capacity (FVC) and diffusing capacity for carbon monoxide were performed as per the American Thoracic Society–European Respiratory Society guidelines. ILD progression was defined as an absolute FVC decline of ≥ 5% over 12 months, with three alternative definitions of ILD progression — an absolute FVC decline of ≥ 10%, progressive pulmonary fibrosis, and progressive fibrosing ILD — all assessed at annual visits. Findings were validated in an enriched cohort comprising 68 patients with SSc-ILD from the main cohort and 53 patients from Michigan (n = 121; mean age, 52 years; 69% women; mean disease duration, 1.3 years). Furthermore, the effects of ILD progression on mortality were assessed. TAKEAWAY: Among patients with initial ILD progression — an FVC decline of ≥ 5% from visit 1 to visit 2 — only 20% showed further progression at visit 3. However, among those without initial progression between visits 1 and 2, 31% showed progression between visits 2 and 3 ( P = .048). = .048). Initial ILD progression with an FVC decline of ≥ 5% reduced the risk for subsequent progression (adjusted odds ratio [aOR], 0.28; P = .002; area under the curve, 0.71). Moreover, no risk was observed for subsequent progression using alternative definitions. = .002; area under the curve, 0.71). Moreover, no risk was observed for subsequent progression using alternative definitions. Similar results were noted in the enriched cohort, with an FVC decline of ≥ 5% from visit 1 to visit 2 reducing the risk for subsequent progression from visit 2 to visit 3 (aOR, 0.22; P = .031). = .031). FVC decline ≥ 5% was associated with an increased risk for mortality in the main cohort (hazard ratio, 1.66; P = .030). IN PRACTICE: 'These results challenge current treatment practices because, although initiating or escalating treatment should still be done in patients with ILD progression according to guidelines, our data suggest that treatment should be initiated or escalated in patients at risk of progression to prevent poor outcomes, although confirmation is needed to show a benefit of this strategy on improved outcome,' the authors wrote. SOURCE: The study was led by Anna-Maria Hoffmann-Vold, MD, Department of Rheumatology, Oslo University Hospital, Oslo, Norway. It was published online on May 14, 2025, in The Lancet Rheumatology. LIMITATIONS: Only patients with consecutive lung function assessments were included, which may have enriched the sample with patients with severe or progressive ILD. Moreover, the findings may not be applicable to other types of ILD. Validation in more diverse populations may be needed as the study predominantly included White patients. DISCLOSURES: The study did not receive any specific funding. Several authors reported receiving speakers bureau and consulting fees, grants, and having other financial relationships with pharmaceutical, biotechnology, and other companies, including Boehringer Ingelheim, Janssen, Medscape, Genentech, Merck Sharp & Dohme, and Roche.


Bloomberg
6 hours ago
- Bloomberg
Former Trump Trade Official: Not Optimistic About US-EU Deal
"The President is turning up the heat to try to get the EU to come to the table," says Kelly Ann Shaw, Partner at Akin and former Deputy Assistant to the President for International Economic Affairs. Nevertheless, she argues, "countries like India, Japan, South Korea will be first, before we see anything with the EU." Shaw speaks to Anna Edwards and Lizzy Burden on 'Bloomberg: The Opening Trade'. (Source: Bloomberg)